Literature DB >> 19321504

Bannayan-Riley-Ruvalcaba syndrome: a cause of extreme macrocephaly and neurodevelopmental delay.

N E Lynch1, S A Lynch, J McMenamin, D Webb.   

Abstract

BACKGROUND: Bannayan-Riley-Ruvalcaba syndrome (BRRS) is an autosomal dominant condition characterised by macrocephaly, developmental delay and subtle cutaneous features. BRRS results from mutations in the PTEN gene. In adults, PTEN mutations cause Cowden syndrome where, in addition to the macrocephaly, there is a higher risk of tumour development. Diagnosis of BRRS is often delayed as presentation can be variable, even within families. AIMS: To identify characteristics of this condition which might facilitate early diagnosis. Prompt diagnosis not only avoids unnecessary investigations in the child but potentially identifies heterozygote parents who are at risk of tumour development. METHODS AND
RESULTS: Six children with a PTEN mutation were identified. All had extreme macrocephaly. Four parents and a male sibling were found to have a PTEN mutation on subsequent testing. Affected parents had extreme macrocephaly and a history of thyroid adenoma, or breast or skin lesions. All six children had presented to medical attention before the age of 2.5 years (3/6 were investigated as neonates), but the median age at diagnosis was 5 years. Four of the children had multiple investigations prior to identification of a PTEN mutation.
CONCLUSION: BRRS should be considered in children with extreme macrocephaly as it is the most consistent clinical feature seen, particularly where there is a family history of macrocephaly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19321504     DOI: 10.1136/adc.2008.155663

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

Review 1.  Ras and Rap signaling in synaptic plasticity and mental disorders.

Authors:  Ruth L Stornetta; J Julius Zhu
Journal:  Neuroscientist       Date:  2010-04-29       Impact factor: 7.519

2.  Superdomains in the protein structure hierarchy: The case of PTP-C2.

Authors:  Donald T Haynie; Bin Xue
Journal:  Protein Sci       Date:  2015-03-31       Impact factor: 6.725

3.  Say What? Bannayan-Riley-Ruvalcaba Syndrome Presenting with Gastrointestinal Bleeding Due to Hamartoma-Induced Intussusception.

Authors:  William Kethman; Aarti Rao; Kelly Devereaux; Etienne Ouellet; Cindy Kin
Journal:  Dig Dis Sci       Date:  2017-09       Impact factor: 3.199

Review 4.  Discovery of Rare Mutations in Autism: Elucidating Neurodevelopmental Mechanisms.

Authors:  Ece D Gamsiz; Laura N Sciarra; Abbie M Maguire; Matthew F Pescosolido; Laura I van Dyck; Eric M Morrow
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

Review 5.  The neurology of mTOR.

Authors:  Jonathan O Lipton; Mustafa Sahin
Journal:  Neuron       Date:  2014-10-22       Impact factor: 17.173

6.  Molecular profiling of endometrial malignancies.

Authors:  Norasate Samarnthai; Kevin Hall; I-Tien Yeh
Journal:  Obstet Gynecol Int       Date:  2010-03-28

7.  Torsion of a giant mesocolic lipoma in a child with Bannayan-Riley-Ruvalcaba syndrome.

Authors:  Benjamin A Laguna; Ramesh S Iyer; Erin R Rudzinski; Jessica L Roybal; A Luana Stanescu
Journal:  Pediatr Radiol       Date:  2014-07-10

8.  Bannayan-Riley-Ruvalcaba syndrome with deforming lipomatous hamartomas in infant--case report.

Authors:  Gabriela Maria Abreu Gontijo; Clóvis Antonio Lopes Pinto; Silvia Regina Rogatto; Isabela Werneck da Cunha; Samuel Aguiar; Célia Antônia Xavier de Moraes Alves
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

9.  Characteristic brain magnetic resonance imaging pattern in patients with macrocephaly and PTEN mutations.

Authors:  Adeline Vanderver; Davide Tonduti; Ilana Kahn; Johanna Schmidt; Livija Medne; Jodie Vento; Kimberly A Chapman; Brendan Lanpher; Phillip Pearl; Andrea Gropman; Charles Lourenco; John-Steven Bamforth; Cynthia Sharpe; Mercédes Pineda; Jens Schallner; Olaf Bodamer; Simona Orcesi; Saskia A J Lesnik Oberstein; Erik A Sistermans; Helger G Yntema; Carsten Bonnemann; Amy T Waldman; Marjo S van der Knaap
Journal:  Am J Med Genet A       Date:  2013-12-20       Impact factor: 2.802

10.  Cognitive characteristics of PTEN hamartoma tumor syndromes.

Authors:  Robyn M Busch; Jessica S Chapin; Jessica Mester; Lisa Ferguson; Jennifer S Haut; Thomas W Frazier; Charis Eng
Journal:  Genet Med       Date:  2013-03-07       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.